First Header Logo Second Header Logo

Connection

Steven Park to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Steven Park has written about Xenograft Model Antitumor Assays.
Steven Park
Connection Strength
0.174
Xenograft Model Antitumor Assays
  1. Au KM, Wang AZ, Park SI. Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma. Sci Adv. 2020 Apr; 6(14):eaaz9798.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.